TQB3117
/ Sino Biopharm
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 16, 2024
A Clinical Trial of TQB3117 Tablets in Patients With Advanced Malignant Cancer
(clinicaltrials.gov)
- P1 | N=59 | Not yet recruiting | Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Metastases • New P1 trial • Oncology
1 to 1
Of
1
Go to page
1